Kymera Therapeutics director Steven Hall not standing for reelection at 2022 annual meeting

Kymera Therapeutics, Inc.

Director Steven Hall informed board he will not stand for reelection at 2022 annual meeting.
Hall's departure is not due to any disagreement with the company.
Hall served on the Compensation Committee; company thanks him for service.
No replacement announced; Hall will serve until end of his current term.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Steven Hall

Director

KYMR · Kymera Therapeutics, Inc.

Filed: April 11, 2022, 7:59 PM ET

On April 6, 2022, Dr. Steven Hall, a member of the Board of Directors (the “Board”) of Kymera Therapeutics, Inc. (the “Company”) and the Compensation Committee of the Board, informed the Company that he does not intend to stand for reelection at the Company’s 2022 annual meeting of stockholders

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Steven Hall departed as Director at Kymera Therapeutics, Inc..

Action: does not intend to stand for reelection
Role: Director

Exact text from the filing

On April 6, 2022, Dr. Steven Hall, a member of the Board of Directors (the “Board”) of Kymera Therapeutics, Inc. (the “Company”) and the Compensation Committee of the Board, informed the Company that he does not intend to stand for reelection at the Company’s 2022 annual meeting of stockholders

View on SEC.gov

Kymera Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-22-101673

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.